MIRA Pharmaceuticals, Inc. Common Stock (MIRA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $27.73M
Last updated: Nov 17, 2026 at 11:03 AM ET
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Stock Forecast
Analysts expect MIRA Pharmaceuticals, Inc. Common Stock (MIRA) to earn -$0.12 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.16.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$0.12
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.16
- EPS consensus
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.12 | -$0.12 to -$0.12 | 1 |
| Dec 31, 2027 | -$0.16 | -$0.16 to -$0.16 | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
Frequently Asked Questions About MIRA
What is the MIRA stock forecast?
Consensus analyst estimates put MIRA Pharmaceuticals, Inc. Common Stock's EPS at -$0.12 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from MIRA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.12, with estimates from -$0.12 to -$0.12 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.16, with estimates from -$0.16 to -$0.16 from 1 analyst.
How many analysts cover MIRA?
1 analyst estimates EPS for MIRA Pharmaceuticals, Inc. Common Stock for the fiscal year ending Dec 31, 2026.
MIRA pages: Overview, Earnings, Forecast, Financials, Competitors